A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/455 (2006.01)
Patent
CA 2299306
A method of treating a human subject to inhibit mutagenic effects of carcinogens by administering to the subject a composition comprising a sufficient amount of 6,6'-dithiodinicotinic acid to inhibit activity of poly(ADP-ribose) polymerase in said subject to thereby inhibit said effects. Also provided is a method of inhibiting occurrence of mutations and of cancers derived from mutations, which method comprises administration to a subject of a composition comprising a sufficient amount of 6,6'-dithiodinicotinic acid.
L'invention concerne un procédé de traitement d'un sujet humain visant à inhiber les effets mutagènes de substances carcinogènes. Ce procédé consiste à administrer à ce sujet une composition renfermant une proportion d'acide 6,6'-dithiodinicotinique suffisante pour inhiber l'activité de la poly(ADP-ribose) polymérase à l'intérieur dudit sujet, et ainsi inhiber les effets susmentionnés. L'invention concerne également un procédé visant à inhiber l'apparition de mutations et de cancers pouvant dériver de ces mutations, ce procédé consistant à administrer au sujet une composition renfermant une proportion suffisante d'acide 6,6'-dithiodinicotinique.
Grassetti Davide R.
Mbm Intellectual Property Law Llp
The Grassetti Family Trust
LandOfFree
Antimutagenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimutagenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimutagenic agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1966386